Literature DB >> 26109444

Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations.

Michael Hogardt1, Timo Wolf2, Gerrit Kann2, Hans-Reinhard Brodt2, Christian Brandt1, Oliver T Keppler3, Sabine Wicker4, Kai Zacharowski5, René Gottschalk6, Stephan Becker7, Volkhard A J Kempf8.   

Abstract

In light of the recent Ebola virus outbreak, it has to be realized that besides medical treatment, precise algorithms for the management of complicating microbial infections are mandatory for Ebola virus disease (EVD) patients. While the necessity of such diagnostics is apparent, practical details are much less clear. Our approach, established during the treatment of an EVD patient at the University Hospital in Frankfurt am Main, Germany, provides a roadmap for reliable and safe on-site microbiological testing.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26109444      PMCID： PMC4609678          DOI： 10.1128/JCM.01142-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  An integrated approach to laboratory testing for patients with Ebola virus disease.

Authors:  Peter C Iwen; Jodi L Garrett; Shawn G Gibbs; John J Lowe; Vicki L Herrera; Anthony R Sambol; Karen Stiles; James L Wisecarver; Kathryn J Salerno; Samuel J Pirruccello; Steven H Hinrichs
Journal:  Lab Med       Date:  2014

2.  Out of Africa--caring for patients with Ebola.

Authors:  Eric J Rubin; Lindsey R Baden
Journal:  N Engl J Med       Date:  2014-11-12       Impact factor: 91.245

3.  Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.

Authors:  Stephan Günther; Heinz Feldmann; Thomas W Geisbert; Lisa E Hensley; Pierre E Rollin; Stuart T Nichol; Ute Ströher; Harvey Artsob; Clarence J Peters; Thomas G Ksiazek; Stephan Becker; Jan ter Meulen; Stephan Olschläger; Jonas Schmidt-Chanasit; Hinrich Sudeck; Gerd D Burchard; Stefan Schmiedel
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Laboratory test support for Ebola patients within a high-containment facility.

Authors:  Charles E Hill; Eileen M Burd; Colleen S Kraft; Emily L Ryan; Alexander Duncan; Anne M Winkler; John C Cardella; James C Ritchie; Tristram G Parslow
Journal:  Lab Med       Date:  2014

Review 5.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

6.  A case of severe Ebola virus infection complicated by gram-negative septicemia.

Authors:  Benno Kreuels; Dominic Wichmann; Petra Emmerich; Jonas Schmidt-Chanasit; Geraldine de Heer; Stefan Kluge; Abdourahmane Sow; Thomas Renné; Stephan Günther; Ansgar W Lohse; Marylyn M Addo; Stefan Schmiedel
Journal:  N Engl J Med       Date:  2014-10-22       Impact factor: 91.245

7.  [Management of highly contagious, life-threatening infectious diseases in Germany].

Authors:  René Gottschalk
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2015-07       Impact factor: 1.513

8.  Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.

Authors:  Timo Wolf; Gerrit Kann; Stephan Becker; Christoph Stephan; Hans-Reinhardt Brodt; Philipp de Leuw; Thomas Grünewald; Thomas Vogl; Volkhard A J Kempf; Oliver T Keppler; Kai Zacharowski
Journal:  Lancet       Date:  2014-12-19       Impact factor: 79.321

9.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  A K Rowe; J Bertolli; A S Khan; R Mukunu; J J Muyembe-Tamfum; D Bressler; A J Williams; C J Peters; L Rodriguez; H Feldmann; S T Nichol; P E Rollin; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  Legionella antibodies in human and animal populations in Kenya.

Authors:  A Phakkey; K J Lindqvist; T Omland; B P Berdal
Journal:  APMIS       Date:  1990-01       Impact factor: 3.205
View more
  3 in total

1.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou
Journal:  Clin Infect Dis       Date:  2016-06-27       Impact factor: 9.079

2.  Whole Blood-Based Multiplex Immunoassays for the Evaluation of Human Biomarker Responses to Emerging Viruses in Resource-Limited Regions.

Authors:  Jessica R Harmon; Stuart T Nichol; Christina F Spiropoulou; Anita K McElroy
Journal:  Viral Immunol       Date:  2017-09-22       Impact factor: 2.257

3.  Experiences and challenges in the health protection of medical teams in the Chinese Ebola treatment center, Liberia: a qualitative study.

Authors:  Ying Li; Huan Wang; Xu-Rui Jin; Xiang Li; Michelle Pender; Cai-Ping Song; Sheng-Lan Tang; Jia Cao; Hao Wu; Yun-Gui Wang
Journal:  Infect Dis Poverty       Date:  2018-08-16       Impact factor: 4.520
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.